Pharma Supplier Hub

Biohit is a Finnish public healthtech company specializing in gastrointestinal diagnostics and related products. It is headquartered in Helsinki and markets products such as GastroPanel, biopsy quick tests for lactose intolerance and H. pylori, and Acetium.

Calla Lily Clinical Care is a UK women’s health medtech company developing the Callavid® intravaginal drug-delivery platform. Its lead programs focus on progesterone delivery for threatened miscarriage and IVF, with future applications in menopause, cancer, infectious diseases, live biotherapeutics, and diagnostics.

Inpart is a life-science partnering platform for discovering, evaluating, and managing external innovation and collaboration opportunities. It combines scientific matchmaking, partnering CRM, scouting campaigns, and alliance workflows for pharma, biotech, academia, and investors.

Inscripta has transitioned into Manus, which now redirects users to Manus Bio, a synthetic biology and biomanufacturing company focused on bio-based alternatives to fossil-derived products. Manus offers end-to-end microbial engineering and fermentation capabilities, while MAD7 genome editing licensing continues via madzymes.com, providing continuity for existing and new licensees.

Insilico Medicine is a clinical-stage biotech company using generative AI platforms like PandaOmics and Chemistry42 to power end-to-end drug discovery and development. It offers licensed AI software and a broad pipeline of oncology, fibrosis, immunology and infectious disease programs, supporting pharma R&D and procurement teams across target discovery, molecule design and early clinical development.

UCB S.A. is a Brussels-based global biopharmaceutical company listed on Euronext Brussels, specializing in innovative therapies for severe neurological and immunological diseases. With over 9,000 employees across nearly 40 countries, the company markets established products including Cimzia, Vimpat, Keppra, Neupro, and Briviact while advancing a robust pipeline of monoclonal antibodies and small molecules. UCB maintains ISO 14001-certified manufacturing and has committed to net-zero emissions by 2045.

INTEGRA Biosciences is a Switzerland-based laboratory equipment company specializing in liquid handling, pipetting automation, and media preparation for pharmaceutical, biotech, and diagnostic laboratories. Founded in 1965, the company serves global markets from headquarters in Zizers, Switzerland, and Hudson, New Hampshire.

InterVenn Biosciences is a private life sciences company using AI-driven glycoproteomics to develop diagnostics and precision medicine solutions. Its proprietary platform enables biomarker discovery, treatment response prediction, and non-invasive tests, particularly in oncology. Headquartered in South San Francisco, InterVenn partners with biopharma and clinical researchers to integrate glycoproteomic insights into clinical workflows.

n6 develops the iconPCR platform, a real‑time NGS library prep thermocycler with AutoNorm adaptive amplification for per‑well cycle control and built‑in normalization. iconPCR and the icon96/icon16 instruments support 16S metagenomics, RNA‑seq, single‑cell and WGS workflows, helping labs cut manual quantification and normalization, reduce failures in low‑input or FFPE samples, and generate consistent, sequencing‑ready libraries in one automated step.

Inventia Life Science provides the RASTRUM 3D cell culture platform, workflow paths, and discovery services to help drug discovery teams generate decision-grade data from human-relevant 3D cell models. Their assay-ready models, Validated Solutions, and Discovery Mode workflows support disease research, target ID, lead validation, mechanism-of-action, and early toxicology while integrating into standard plate-based lab workflows.

IQVIA is a global life-science partner providing advanced analytics, Healthcare-grade AI, clinical research and technology solutions to accelerate drug development and commercialization. Through IQVIA Connected Intelligence, it integrates rich healthcare data, AI, and domain expertise to optimize clinical trials, real world evidence, safety and commercial performance for pharmaceutical and biotech companies worldwide.

IROA Technologies is a private metabolomics company providing stable isotope–labeled standards, software, and the TruQuant workflow to correct mass spectrometry errors and improve data reproducibility. Its solutions integrate authentic metabolite standards, suppression correction, and normalization to support reliable clinical and biomarker-focused metabolomics research. The company also offers resources and publications to help labs implement automated, high-quality metabolomics workflows.

FUJIFILM Biosciences (formerly FUJIFILM Irvine Scientific) is a FUJIFILM life sciences company specializing in cell culture media, reagents, and workflow technologies for bioprocessing, cell therapy, gene therapy, and disease modeling. Headquartered in Santa Ana, California, it offers standard and custom media, development services, and tools such as Oceo Rover to help biopharma scale from discovery through commercial manufacturing.

Izon Science makes lab equipment for isolating and analyzing nanoparticles, especially extracellular vesicles and lipid nanoparticles. Its core portfolio includes qEV isolation platforms and TRPS-based instruments such as Exoid for particle size, concentration, and zeta potential measurement.

JPT Peptide Technologies is an ISO 9001:2015-certified German peptide specialist offering custom peptide synthesis, peptide libraries, pools, microarrays and a broad catalog of research peptides. With more than 20 years of experience and proprietary high-throughput technologies, JPT supports cell therapy, vaccines, immunology, neo-epitope discovery, proteomics and COVID-19 research from micro-scale to gram-scale peptide manufacturing.

Journey is a privately held global design and innovation agency that creates multidimensional experiences (MDX) connecting people, brands and culture across physical, immersive, digital and virtual spaces. Headquartered in New York with hubs in London, Miami and Abu Dhabi, Journey produces story-driven, sensory-rich environments and experiences for leading institutions and brands worldwide.

KBI Biopharma is a global CDMO specializing in complex biologics, integrating cell line, process, analytical and formulation development with clinical and commercial GMP manufacturing. The company supports mammalian and microbial programs using proprietary SUREtechnology (CHO) and PUREplatform (E. coli) platforms and offers a dedicated analytics portal for streamlined standalone testing. Its services span first-in-human through commercial supply for biologics and vaccines.

KEYENCE CORPORATION OF AMERICA is the U.S. arm of KEYENCE, supplying advanced automation, measurement and imaging equipment. Its portfolio spans sensors, machine vision, microscopes, 3D profilers and laser profilers, with fast delivery and extensive application support for manufacturing, QA and R&D environments, including pharma and biotech.

BellBrook Labs, based in Madison, Wisconsin, provides Transcreener, AptaFluor and Enzolution high-throughput biochemical assay kits for kinase and other enzyme targets. Its universal, mix-and-read assay platforms support inhibitor screening, selectivity profiling and mechanistic studies across thousands of enzymes involved in DNA damage repair, innate immunity and cell signaling.

Kisaco Research is a private B2B events organiser that designs and hosts intensively researched conferences, exhibitions and networking platforms across health, tech, legal and consumer markets. For pharma and healthcare stakeholders, it provides neutral forums on topics such as drug development, IP, payment integrity and innovation, helping R&D and procurement teams access knowledge, peers and potential partners.

Kosten Digital, Inc. is a private U.S.-based IT and AI solutions provider focused on life sciences and healthcare. It designs, builds and operates tailored AI-first digital products and data-driven platforms for health systems, pharma, biotech, payors and regulators, helping them address data silos, compliance and decentralized manufacturing while advancing precision medicine and predictive insights.

Kosten Digital, Inc. is a private IT and AI solutions company focused on life sciences and healthcare, delivering tailored AI-first software, data and applied AI services to streamline operations, unlock data value and improve patient outcomes. Through its Design, Build and Operate "Kosten Way" approach, it supports hospitals, biotech, insurers, CDMOs, CROs and regulators with secure, compliant digital transformation across clinical and operational workflows.

SCIEX is a leading provider of LC‑MS, capillary electrophoresis and analytical software solutions used across clinical diagnostics, environmental and food testing, forensics and pharma/biopharma research. Its portfolio includes mass spectrometers, clinical IVD devices, CE instruments, HPLC‑MS front‑ends, SCIEX OS software and integrated workflows, all supported by a global service network and Danaher’s Life Sciences platform.

HTA S.R.L. is an Italian designer and manufacturer of autosamplers and automated sample preparation workstations for chromatography and spectroscopy analyzers. From GC, HPLC and IC autosamplers to LEANPREP sample prep solutions, HTA supports more than 400 analyzer models in over 80 countries and integrates with major CDS platforms. Its portfolio targets analytical, life science and clinical labs seeking reliable, robotics-based automation.